Vera Therapeutics VERA Insider Ownership

NASDAQ VERA

$30.53 +0.47 (+1.56%)

As of: Oct 21, 2026 · 10:57 AM EDT

Insider Holdings by Owner

16.28Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

12.68%

▲+0.070% pp QoQ

Shares Held by Insiders

9.11Mn

filed for Sep 2026

▲+0.55% QoQ

Shares Outstanding

71.84Mn

71,838,008 shares

Direct Holdings

910.35K

Indirect: 8.20Mn

Net Shares Traded (QoQ)

+49.99K

net buying in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 5, 2026

Over the past year, VERA insiders bought $249,985 of stock (5.88K shares) and sold $8.99 million (225.56K shares) on the open market.

Counted by insider, open-market buying of VERA stock in the past 12 months came from one insider and selling from 8 insiders.
Among Vera Therapeutics' insiders, the largest open-market purchases in the past 12 months were by Patrick G. Enright (Director), totaling $249,985 (5.88K shares), most recently on December 11, 2025.
On the selling side, Marshall Fordyce (President and CEO) was the top open-market seller of Vera Therapeutics over the past 12 months, with $6.39 million sold (160.13K shares) and the latest sale on September 15, 2026.
In transactions other than open-market trades, Vera Therapeutics insiders received 211.19K shares in stock awards and acquired 156.75K shares through option exercises and conversions over the past 12 months.
Business Quant data shows Vera Therapeutics insiders holding 9.11Mn shares in total in their latest Form 4 filings, or 12.68% of the 71.84Mn shares outstanding; that total is up 0.55% from 9.06Mn shares at the end of Q2 2026.
Vera Therapeutics insiders hold 910.35K shares directly (10.00% of their total) and 8.2Mn shares (90.00%) indirectly, through entities such as trusts and partnerships.
Holdings in Vera Therapeutics stock are reported by 13 insiders, the officers, directors and 10% owners who have filed a Form 4 in the past two years.
Vera Therapeutics' top three insider holders by shares held are Patrick G. Enright (Director, 5.4Mn shares), Maha Katabi (Director, 2.79Mn shares) and Marshall Fordyce (President and CEO, 235.24K shares).
Of the shares held by VERA insiders, 59.29% belong to Patrick G. Enright.
Over the trailing 12 months, 19 insiders reported transactions in VERA stock across 42 Form 4 filings.
This summary of Vera Therapeutics insider activity covers Form 4 filings through September 17, 2026.

Form 4 Holdings

Insiders Holding VERA

Insiders 19

Shares held 16.28Mn

Of outstanding 22.67%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Capital Lp Commodore	TenPercentOwner	0	4,400,000	4,400,000	27.0%	12 Jan, 2024
2	Venture Partners X, L.P. Sofinnova	TenPercentOwner	3,467,156	0	3,467,156	21.3%	08 Feb, 2023
3	Group Inc. Carlyle	TenPercentOwner	0	2,960,231	2,960,231	18.2%	19 Aug, 2022
4	Maha Katabi	Director	0	2,793,987	2,793,987	17.2%	25 Mar, 2024
5	Capital Partners Iv, Llc Longitude	TenPercentOwner	0	1,714,285	1,714,285	10.5%	08 Feb, 2023
6	Marshall Fordyce	President And Ceo	235,244	0	235,244	1.4%	17 Sep, 2026
7	Beth C Seidenberg	Director	131,553	0	131,553	0.8%	30 Oct, 2024
8	Sean Grant	Chief Financial Officer	114,181	0	114,181	0.7%	25 Feb, 2026
9	Joseph R Young	Svp, Finance, Chief Acct Offcr	80,754	0	80,754	0.5%	14 Sep, 2026
10	Laurence Matthew Skelton	Chief Commercial Officer	64,218	0	64,218	0.4%	25 Feb, 2026
11	Robert Brenner	Chief Medical Officer	50,947	0	50,947	0.3%	25 Feb, 2026
12	Jason S Carter	Chief Legal Officer	49,136	0	49,136	0.3%	25 Nov, 2025
13	David Lee Johnson	Chief Operating Officer	45,727	0	45,727	0.3%	25 Feb, 2026
14	William D. Turner	Chief Regulatory Officer	45,313	0	45,313	0.3%	25 Feb, 2026
15	Nancy Lee Boman	Chief Regulatory Officer	44,987	0	44,987	0.3%	05 Aug, 2026
16	Jane Wright-Mitchell	Chief Legal Officer	42,403	0	42,403	0.3%	25 Mar, 2026
17	Joanne Curley	Chief Development Officer	26,962	0	26,962	0.2%	23 Aug, 2023
18	Celia Lin	Chief Medical Officer	11,010	0	11,010	0.1%	23 Aug, 2023
19	Patrick G Enright	Director	5,882	0	5,882	0.0%	15 Dec, 2025

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

568 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
15 Sep, 2026	Marshall Fordyce	President And Ceo	Acquired M	18,500	$2.90	$53.59K	253,744	Direct
15 Sep, 2026	Marshall Fordyce	President And Ceo	Disposed S	18,500	$37.00	$684.50K	235,244	Direct
15 Sep, 2026	Marshall Fordyce	President And Ceo	Disposed M	18,500	$0.00	$0	488,801	Direct
11 Sep, 2026	Joseph R Young	Svp, Finance, Chief Acct Offcr	Acquired M	5,000	$3.94	$19.70K	80,754	Direct
11 Sep, 2026	Joseph R Young	Svp, Finance, Chief Acct Offcr	Disposed M	5,000	$0.00	$0	33,589	Direct
02 Sep, 2026	Marshall Fordyce	President And Ceo	Acquired M	18,500	$2.90	$53.59K	253,744	Direct
02 Sep, 2026	Marshall Fordyce	President And Ceo	Disposed S	18,500	$35.12	$649.64K	235,244	Direct
02 Sep, 2026	Marshall Fordyce	President And Ceo	Disposed M	18,500	$0.00	$0	507,301	Direct
07 Jul, 2026	Marshall Fordyce	President And Ceo	Acquired M	46,250	$2.90	$133.98K	281,494	Direct
23 Jun, 2026	Marshall Fordyce	President And Ceo	Acquired M	18,500	$2.90	$53.59K	253,744	Direct
07 Jul, 2026	Marshall Fordyce	President And Ceo	Disposed S	1,000	$40.78	$40.78K	280,494	Direct
23 Jun, 2026	Marshall Fordyce	President And Ceo	Disposed S	18,412	$37.93	$698.39K	235,332	Direct
23 Jun, 2026	Marshall Fordyce	President And Ceo	Disposed S	88	$38.43	$3.38K	235,244	Direct
07 Jul, 2026	Marshall Fordyce	President And Ceo	Disposed S	32,550	$42.07	$1.37Mn	247,944	Direct
23 Jun, 2026	Marshall Fordyce	President And Ceo	Disposed M	18,500	$0.00	$0	572,051	Direct
07 Jul, 2026	Marshall Fordyce	President And Ceo	Disposed S	10,500	$42.86	$450.01K	237,444	Direct
07 Jul, 2026	Marshall Fordyce	President And Ceo	Disposed S	2,200	$43.59	$95.91K	235,244	Direct
07 Jul, 2026	Marshall Fordyce	President And Ceo	Disposed M	46,250	$0.00	$0	525,801	Direct
03 Aug, 2026	Nancy Lee Boman	Chief Regulatory Officer	Acquired A	44,987	$0.00	$0	44,987	Direct
03 Aug, 2026	Nancy Lee Boman	Chief Regulatory Officer	Acquired A	63,011	$0.00	$0	63,011	Direct

Showing 1 to 20 of 568 transactions